[IgA nephropathy and intrahepatic percutaneous portosystemic shunt].
Blanco Sampascual
S
S
de las Heras Niño
B
B
Marcé Landeta
L
L
Orive Cura
V
V
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D005500:Follow-Up Studies; D005922:Glomerulonephritis, IGA / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D016030:Kidney Transplantation; D008104:Liver Cirrhosis, Alcoholic / Q000150:complications / Q000628:therapy; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D011170:Portasystemic Shunt, Surgical / Q000009:adverse effects*; D011241:Prednisone / Q000627:therapeutic use; D013997:Time Factors
D000893:Anti-Inflammatory Agents; D011241:Prednisone